Dr. Prof Suresh H. Advani, Dr. Suresh Hariram Advani

Senior Consultant

55+ Years of Experience

Hepatologist, Medical Oncologist

MBBS, MD, FICP, MNAMS, FNAMS, Fellowship

Reg. No.:25840 Maharashtra Medical Council, 1970

Nanavati Super Specialty Hospital, Mumbai

English, Gujarati, Hindi

Consultation Fee ₹ 2000

WhatsApp Us

About Dr. Prof Suresh H Advani

Dr. Suresh H. Advani, a pioneering figure in Indian oncology, has dedicated over five decades to clinical and academic leadership. A graduate of Grant Medical College in Mumbai, he trained in hematology-oncology and internal medicine before advancing his expertise in bone marrow transplantation at the Fred Hutchinson Cancer Research Center in Seattle.

He served as Chief of Medical Oncology at Tata Memorial Hospital from 1985 and later established oncology departments at Jaslok and Apollo Hospitals. Dr. Advani's chemotherapy initiatives led to the introduction of hematopoietic stem cell transplantation in India, making him one of the best Oncologists in Mumbai.

Dr. Suresh H Advani’s Expertise & Specializations

Blood Cancer Management: As a Cancer Specialist in Mumbai, he pioneered bone marrow and hematopoietic stem-cell transplantation at the Nanavati Max Oncology Department in India, treating complex blood cancers such as leukemia, lymphoma, and multiple myeloma.
Medical Oncology Expert: His medical oncology focus includes the management of solid tumors such as breast cancer, lung cancer, and colorectal cancer, making him one of the leading Medical Oncologists at Nanavati Max.
Hematological Malignancy Management: He has extensive expertise in the management of hematological malignancies, including lymphomas, acute leukemias, and multiple myeloma.
Immunotherapy and Targeted Therapy: He works on developmental therapeutics and targeted biologics, leveraging immunotherapies and molecularly guided treatments for precision care.

Top Procedures Performed by Dr. Suresh H Advani and Their Costs

Here are some of the procedures performed by Dr. Advani, a top Oncologist in Mumbai.

Procedure	Approx. Fee (INR)	Approx. Fee (USD)
Bone Marrow / Stem-Cell Transplant	20,00,000–40,00,000	24,000–48,000
Day-Care + Targeted Therapy	50,000–3,00,000	600–3,600
Immunotherapy / Biologics	2,00,000–8,00,000	2,400–9,600

Note: Prices may vary depending on the number of cycles.

Some Noteworthy Patient Reviews for Dr. Suresh H Advani

Dr. Suresh H Advani's reviews indicate excellent diagnosis and accurate medication, often described as a godsend for patients.

“One of the finest and most humble human beings you could meet. He is patient, answers your umpteen questions, and is extremely kind.”

“Very nice...good behaviour of the doctor, good memory of him even after 13 years of treatment. Always good guidance.”

“Dr. Advani is a very experienced doctor. He understood my medical case and recommended me the best way forward.”

An appointment with Dr. Suresh H Advani can be made via the MediJourney website. For Dr. Suresh H. Advani's contact number, you can refer to the individual hospital websites.

Book Your Appointment With Dr. Prof Suresh H Advani

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Query

Education

MBBS - Grand Medical College & Sir J.J Group of Hospitals, Mumbai, 1969
MD (General Medicine) - Bombay University, Mumbai, 1973
Fellowship of Yamagiwa-Yoshida Memorial International Cancer Study Grant of the International Union Against Cancer (UICC), 1986
Fellowship of the Indian College of Pathologists (FICP), 1992
Member of National Academy of Medical Sciences (MNAMS,) 1995
Fellow of National Academy of Medical Sciences (FNAMS), 1996

Training & Certificates

ICRETT, Fred Hutchinson Cancer Research Center, Seattle (Bone Marrow Transplant training), 1981
Fellowship – Yamagiwa Yoshida Memorial, UICC, 1986

Past Experience

Chief, Medical Oncology – Tata Memorial Hospital, Mumbai
Founder & Head – Oncology Dept, Jaslok Hospital, Mumbai
Senior Consultant & Mentor – Apollo Hospitals (Navi Mumbai), Sir HN Reliance Foundation & Others
Professor & Guide – DM Oncology, Tata Memorial / Mumbai University

Awards

Padma Shri (2002)
Dhanvantari Award (2002)
Dr B.C. Roy National Award (2005)
Lifetime Achievement in Oncology – Harvard Medical International (2005)
Padma Bhushan (2012)
Rashtriya Krantiveer Award (2014)

Associations/Membership

Indian Society of Oncology (President 1999–2000)
Fellow – National Academy of Medical Sciences (1996)
Medical & Pediatric Oncology Society (President 1991–1994)
Secretary – Indian Journal of Hematology & Blood Transfusion (1986–1988)
Editorial Board – API Journal

Paper Published

He has published over 654 research articles and papers. Some of them are:

AN Bhisey, SGA Rao & SH Advani. Alterations in electrophoretic mobility of mouse macrophages treated with microtubule inhibitors. Ind. J. Expt. Biol. 15: 970-972, 1972.
VR Joshi, SH Advani, MA Ahmed. Abnormal precordial pulsation. Maharashtra Med. Journal 20; 107, 1973.
GS Sainani, SJ Shah, VR Joshi, SH Advani. Sick sinus syndrome.Ind. Heart Journal 25; 178, 1973.
SH Advani, MA Ahmed, VR Joshi. Aneurysm of the sinus of Valsalva. J. Indian Med. Association 65: 154, 1975.
GS Sainani, VR Joshi, SH Advani, UL Wagholikar. Myocardial abscess. Ind. Heart Journal 27; 66, 1975.
SH Advani. Advances in chronic myeloid leukemia therapy. Maharashtra Med. Jour. XXIII; 279, 1975.
Advani SH. Letter: Acute myeloid leukemia with Burkitt’s tumor cells. Blood. Dec: 46 (6)990-2, 1975.
AG Khare, AN Bhisey, SH Advani, KJ Ranadive. Cytogenetic studies in myeloproliferative disorders. Proceedings of a symposium on structural & functional aspects of chromosome 25-26; 241, 1975.
JS Nadkarni, JJ Nadkarni, SS Ranade, RS Chougule, SR Kasturi, SH Advani. In vitro studies on human leukemic cells by pulsed nuclear magnetic resonance, compared with membrane-specific immunofluorescence reactivity. Indian Journal of Cancer 13; 76-80, 1976.
SH Advani, GV Talwalkar, JS Nadkarni, JJ Nadkarni, SM Sirsa, U Srinivasan.Hairy cell leukemia. Ind. J. Cancer 13; 283-287, 1976.
BP Gothoskar, H. D'silva, H. Gharpure, SH Advani. Leucocyte migration studies in chronic myeloid leukemia (CML): specificity of reaction. Europ. J. Cancer 12; 815-821, 1976.
SG Gangal, BP Gothoskar, CS Joshi, SH Advani. Demonstration of cellular immunity in chronic myeloid leukemia using leucocyte migration inhibition assay: Brit. J. Cancer 33; 267-272, 1976.
Sastry PSRK, Advani S.H.; Inhalational GM-CSF to reduce pulmonary morbidity in Bone Marrow Cell Transplantation. Bulletin of the Jaslok Hospital & Research CenPSRK3.
PSRK Sastry, Anjana Sainani, S.H. Advani: Thrombotic Complications of Anti-angiogenic Therapy – a case report. Bulletin of the Jaslok Hospital & Research Centre, Vol. XXVII No. 4, 2003
S. Somjee, S.K. Pai, S.H. Advani: Evolution of chemotherapy in Osteosarcoma; I.J.M.P.O. Vol. 22 No. 3,4.
Suresh H. Advani, Chetna A Bakshi, Ashish V Bakshi: Breast Cancer Management: Role of Chemotherapy; JIMSA April-June 2003 Vol. 16 No.2
Somjee S, Jindal R, Advani SH: Benign multilocular cystic nephroma. Indian J Pediatr. 2003 Jun;70(6):515-7
Siraj AK, Kamat S, Gutierrez MI, Banavali S, Timpson G, Sazawal S, Bhargava M, Advani S, Adde M, Magrath I, Bhatia K. Frequencies of the significant subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West. Leukemia, 2003 Jun; 17(6): 1192-3.
Das M, Saikia TK, Advani SH, Parikh PM, Tawde S.: Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia. Bone Marrow Transplant. 2003 Jul;32(2):125-9.
Amare PS, Pais A, Nair C, Banavali S, Advani SH: Translocation (8;20), a variant of t(8;21), in T-acute lymphoblastic leukemia: a first report. Cancer Genet Cytogenet. 2003 Aug: 145 (1):88-90.
K Ansari, A Clerk, MH Patel, AnjanPSRKinani, PSRPSRKstry, SH Advani: Hypercalcemia Induced by parathyroid hormone-related peptide after treatment of squamous cell carcinoma of the oral cavity—case report. JAPI, Vol 51, October 2003; 1023-1024.
Chetna Bakshi, Shripad Banavali, Nilesh Lokeshwar, Rajendra Prasad, Suresh Advani: Clustering of Fournier (Male Genital) Gangrene Cases in a Pediatric Cancer Ward. MPO. 10110 page 472-474.
Chetna Bakshi, Pratibha Amare (Kadam), Dhiraj Abhyankar, Chanda Baisane, Shripad Banavali, Suresh Advani: Chromosomal Rearrangement in Down Syndrome with Acute Myeloid Leukemia. Indian Journal of Pediatrics, Vol. 70- September, 2003; 755-758.
Reetu Jain, S.H. Advani, A. Sainani, ChetPSRKi, P.SPSRKstry, Caspofungin – The first Echinocandin antifungal drug. Bulletin of the Jaslok Hospital & Research Centre, Vol. XXVIII No. 2, 2003;33-37
Unmesh Mohite, Mayukh Das, Tapan Saikia, Purvish Parikh, R. Gopal, R. Ke, Lkar, and Suresh Advani. Mycobacterial Pulmonary Infection Post Allogeneic Bone Marrow Transplantation. Leukemia and Lymphoma, 2001. Vol. 40(5-6), pp. 675-678
Metkar SS, Manna PP, Anand M, Naresh KN, Advani SH, Nadkarni JJ. CD 40 Ligand anti-apoptotic molecule in Hodgkin’s Disease. Cancer BiotherRadiopharm. 2001 Feb:16(1):85-92.
Amare Kadam PS, Varghese C, Bharde SH, Narasimhamoorthy NK, Desai S, Advani SH, Havaldar R, Kulkarni JN. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.Cancer Genet Cytogenet. 2001 Mar;125(2):139-46.
Arya S, Dhond S, Shinde S, Badrinath Y, Mahadik S, Sapre R, Kumar A, Chougule A, Ansari R, Nair C, Advani S.H. Splenic Lymphoma with Villous Lymphocytes a Laboratory Review of Six Cases Indian Journal of Hematology & Blood Transfusion, Volume XIX No.2, June 2001. P-31
D Abhyankar, Swati Bajpai, T Saikia, R Gopal, C N Nair, S H Advani 2CdA in the Treatment of Hairy Cell Leukemia JAPI, Vol. 49, pp 785-787, August 2001.
D. Abhyankar, T. Saikia and S. Advani Gynecomastia in a Case of Hairy Cell Leukemia – Cladribine Induced Leukemia and Lymphoma, 2001, Vol. 42(1-2), pp. 243-246.
Agarwal P., Ranjan S., Sharma L., Nikam A., Parikh P., Saikia T., Advani S., Gemtuzumab Ozogamicin (Mylotarg) – Drug Review Indian J. Hemat & Blood Transf. 2001; Vol. 19: No. 3; 74-75.
B B Yeole, S.H. Advani, and Lizzy Sunny. Epidemiological features of childhood cancers in Greater Mumbai Journal of the Indian Academy of Pediatrics, Indian Pediatrics-2001, Vol. 38, November 2001, pp 1270-76.
Saikia TK, Menon H, Advani SH. Prolonged neutropenia following anti-CD20 therapy in a patient with relapsed follicular non-Hodgkin’s Lymphoma and corrected with IVIG. Ann Oncol. 2001 Oct; 12(10):1493-4.
P.S. Amare, C. Baisane, T. Saikia, R. Nair, H. Gawade, S. Advani.Fluorescence in situ hybridization: a highly efficient molecular diagnosis and prediction technique for disease course in patients with myeloid leukemias.Cancer Genetics and Cytogenetics 1131(2001), 125-134.
B Byeole, A.P. Kurkure, S.H. Advani, Sunny Lizzy. An Assessment of Cancer Incidence Patterns in Parsi and Non-Parsi Populations, Greater Mumbai. Asian Pacific Journal of Cancer Prevention, Vol 2, 2001;2(4):293-298.
Abhyankar D, Menon H, Saikia T, Advani S. Rhinocerebral Mucormycosis infection in Multiple Myeloma: A Case Report Indian Journal of Hematology & Blood Transfusion, pp. 97, December 2001.
Jyoti Kode, Suresh Advani, and Shubhada Chiplunkar. T-cell receptor and Gene Rearrangements in T-cell Acute Lymphoblastic Leukemia in Indian Patients. Leukemia and Lymphoma 2000, Jan;36(3-4)331-8.
K.N. Naresh, J. Johnson, V. Srinivas, CS Soman, T. Saikia, S.H. Advani, R.A. Badwe, K.A. Dinshaw, M. Muckadem, I. Magrath, and K. Bhatia. Epstein-Barr virus association in classical Hodgkin’s Disease provides a survival advantage to patients and correlates with higher expression of proliferation markers in Reed-STe—Sternberg cells. Annals of Oncology 11, 91-96: 2000.
Y. Nerurkar, P. Vijayan, V. Srinivas, C.S. Soman, K.A. Dinshaw, S.H.Advani, I. Magrath, K. Bhatia, and K.N. Naresh. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin’s disease: Impact on pathogenesis. Annals of Oncology 11: (4):475-8: 2000.
Dhiraj Abhyankar, Reena Nair, Hari Menon, Bhupendra Kapoo, and Suresh Advani. Avascular Necrosis of Head of Femur in a Patient with Acute Promyelocytic Leukemia. Leukemia and Lymphoma 37(5):635-637, 2000.
Abhyankar D and Advani SH. Cladribine (Drug Review) Background and Drug Development. Indian J. Hemat & Blood Tranf 18(1):19-21, 2000.
Mohite U, Das M., Parikh PM, Saikia TK, Gopal R, Mohite M, Todankar H, and Advani SH. Cyclosporine-Associated Fever in a Patient Undergoing Allogeneic Bone Marrow Transplantation. Ind. J. of Hemat. & Bl. Transf. 18(1):11, 2000.
Letter to Editor, Kulkarni K. Reply: Parikh PM, Hiwase DK, Pai VR, Gopal R, Saikia TK, and Advani SH. Indian J. of Hemat. & Blood Transf. 18(1):22-23,2000.
Nishigandha Naik, Jean-Paul Rigaut, Suresh Advani, and Avinash Bhisey: Differences in the microtubule organization between normal and CML granulocytes after stimulation with chemotactic peptide. Cell Biology International 24, (3) 135-144, 2000
V. Radhika,N. R.. NaikS. H.H. Advani and A.N. Bhisey Actin Polymerization in Response to Different Chemoattractants is Reduced in Granulocytes from Chronic Myeloid Leukemia Patients Cytometry (communications in clinical Cytometry) 42:379-386(2000)
D. Abhyankar, Chetna Shende, T. Saikia, S. Advani Hydroxyurea Induced Leg Ulcers JAPI 2000, Vol. 48, No.9, PP 926-927.
D. Abhyankar, T. Saikia & S. Advani Gynecomastia in a Case of Hairy Cell Leukemia - Cladribine Induced. Leukemia and Lymphoma,2000, Vol. 7, pp 1-4.
Bapna A., Abhyankar D., Amare(Kadam)P., Gladstone B., Advani S. Relapse with Acute Myeloblastic Leukemia(M2) in Acute Promyelocytic Leukemia(M3): A Case Report Indian J. Hemat & Blood Transf. 2000; Vol. 18: No. 3;, 60-61
D. Abhyankar, B Kapoor, and S.H. Advani. Newer Strategies in HematoOncology. API- Assam Chapter, MedicinMillennium Update-2000. P. 186-203, Vol. No. 1, 2000.
D.K. Hiwase, A. Mukhopadhyay, P.M. Parikh, R. Gopal, T.K. Saikia, V.R. Pai, S.S. Menon & S.H. Advani. Ceftazidime and Netilmicin Versus Ceftazidime and Amikacin for Febrile Neutropenia. Indian Journal of Medical & Pediatric Oncology, Vol 21 No. 1, March 2000 pp 21-27.
Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, Caviles AP, Tee GY, Chasen MR, Fahed Z, Chao TY, Aydogdu I, Lynott AM. A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study. Leuk Lymphoma 2000 Apr;37(3-4):367-77.
Arati Rao, N.A. Jambhekar, Chandrika N Nair, R.K. Deshpande, S.C. Pande, S.H. Advani. Undifferentiated (Embryonal) Sarcoma of the Liver. Indian Journal of Medical & Pediatric Oncology, Vol 21 No.2, June 2000 pp 48-50.
Rathore VB, Advani SH, Nadkarni JJ. A high cytosolic pool of p75 TNF receptors and delayed surface-down modulation by mononuclear cells from non-Hodgkin’s lymphoma patients. Cytokine 2000 Jul;12(7):1142-6.
Metkar SS, Naresh KN, Manna PP, Srinivas V, Advani SH, Nadkarni JJ. Circulating levels of TNF alpha and TNF receptor superfamily members in lymphoid neoplasia. Am J Hematol. 2000 Oct;65(2):105-10.
Giles FJ, Shan J, Advani SH, Akan H, Aydogdul I, Aziz Z, Azim HA, Bapsy PP, Buyckkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Itragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S: International Oncology Study Group NHL 1 Study. A prospective randomized study of CHOP versus CHOP plus Alpha-2B Interferon in patients with intermediate and high-grade Non-Hodgkin’s Lymphoma: the International Oncology Study Group NHL 1 Study. Leuk Lymphoma 200Dec: 40 40(1-2)95-103.
Limited Efficacy of ticarcillin-clavulanic acid and amikacin in the empiric treatment of febrile neutropenia in children with hematolymphoid malignancies. Anupama Broker, Indumati Ambulkar, Nilesh Lokeshwar, R Gopal, SH Advani, Indian Pediatrics, February 2008.
Patkar N, Mehta J, Kulkarni B, Pande R, Advani S, Borges A: Immunoprofile of Hodgkin’s Lymphoma in India. Indian Journal of Cancer, April –June 2008; volume 45, issue 2: 59-63.

Field of Expertise

Acute Lymphoblastic Leukemia Treatment
Acute Myeloid Leukemia (AML) Treatment
Adrenal Cancer Treatment
Allogeneic Bone Marrow Transplant
Autologous Bone Marrow Transplant
Bacillus Calmette Guerin (BCG) Therapy
Benign and Cancerous Tumor Excision
Bile Duct Cancer Treatment
Bone Marrow Transplant
Brachytherapy Treatment
Brain Tumor Surgery
Breast Biopsy
Breast Cancer Treatment
Cancer Treatment
CAR T-Cell Therapy
Carcinoid Tumor Treatment
Castleman Disease Treatment
Cervical Cancer Treatment
Chemotherapy
Chronic Lymphocytic Leukemia Treatment
Chronic Myeloid Leukemia Treatment
Colon Cancer Surgery
Colorectal Cancer Treatment
Completion Thyroidectomy
CyberKnife Surgery
Endometrial Cancer Treatment
Endoscopic Tumor Removal
Ewing Family of Tumors Treatment
Fine Needle Aspiration
Genitourinary Cancer Treatment
Gestational Trophoblastic Disease (GTD) Treatment
Haplo–Allogeneic Bone Marrow Transplant
Hematopoietic Stem Cell Transplantation (HPSCT)
High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
Hormone Therapy
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Image-Guided Radiation Therapy (IGRT)
Immunotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Kaposi Sarcoma Treatment
Leukemia Treatment
Liver Cancer Treatment
Lumpectomy
Lung Cancer Treatment
Malignant Mesothelioma Treatment
Metastatic Tumor Treatment
Minimally Invasive Cancer Surgery
Multiple Myeloma Treatment
Nasal Cavity and Paranasal Sinus Cancer Treatment
Nasopharyngeal Cancer Treatment
Non-Small Cell Lung Cancer (NSCLC) Treatment
Oncological Surgery
Ovarian Cancer Treatment
Papillary Thyroid Cancer Treatment
Pediatric Bone Marrow Transplant
Pediatric Leukemia Treatment
Penile Cancer Treatment
PET CT Scan
Proton Therapy
Radiation Therapy
Radioisotope Therapy
Rhabdomyosarcoma (RMS) Treatment
Robotic Cancer Surgery
Sickle Cell Anemia Treatment
Skin Lymphoma Treatment
Small Intestine Cancer Treatment
Stem Cell Transplant
Stomach Cancer Treatment
Targeted Therapy
Thymectomy
Thymoma and Thymic Carcinoma Treatment
Thyroid Cancer Treatment
Transarterial Chemoembolization (TACE)
Vaginal Cancer Treatment
Vulvar Cancer Treatment
Whipple Procedure
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia (AML)
Acute Promyelocytic Leukemia (APL)
Adenocarcinoma
Adenosquamous Carcinoma
Adrenocortical Carcinoma
Adult Hodgkins Lymphoma
AIDS-Related Cancer
Ameloblastoma
Anal Cancer
Anaplastic Carcinoma
Anemia
Aplastic Anemia
Appendix Cancer
Atypical Hyperplasia
Atypical Spindle Cell Tumor
Atypical Teratoid/Rhabdoid Tumor (ATRT)
Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma of the Skin
Benign Bone Tumors
Benign Hematology
Benign Lung Tumors
Benign Soft Tissue Tumors
Bile Duct Cancer, Stones, & Strictures
Bladder Cancer
Blood Cancer
Bone Cancer
Bone Marrow Cancer
Breast Cancer
Breast Cancer During Pregnancy
Breast Cancer Recurrence
Bronchial Tumors
Burkitt Lymphoma
Cancer in Children
Carcinoid Syndrome
Carcinoid Tumor (Gastrointestinal)
Carcinoid Tumors of the Lungs
Cervical Cancer
Childhood Acute Lymphoblastic Leukemia
Cholangiocarcinoma
Chronic Granulomatous Disease (CGD)
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia
Chronic Myeloid Leukemia (CML)
Chronic Myeloproliferative Neoplasms
Colorectal Cancer
Cutaneous T-Cell Lymphoma
Cyclic Neutropenia
Desmoid Tumor
Diamond-Blackfan Anemia (DBA)
Ductal Carcinoma in Situ (DCIS)
Dyskeratosis Congenita (DKC)
Elevated PSA (Prostate-Specific Antigen) Level
Embryonal Tumors
Eosinophilia
Eosinophilic Disorders
Esophageal Cancer
Esophagectomy
Essential Thrombocythemia
Esthesioneuroblastoma
Estrogen Dependent Cancers
Ewing Sarcoma
Extracranial Germ Cell Tumor
Extragonadal Germ Cell Tumor
Extrahepatic Bile Duct Cancer
Fallopian Tube Cancer
Familial Adenomatous Polyposis (FAP)
Familial Adenomatous Polyposis (FAP): Inherited
Fanconi Anemia (FA)
Follicular Lymphoma
Free Flap Surgery for Treating Osteoradionecrosis
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST)
Gestational Trophoblastic Disease
Giant Cell Tumor
Gum Tumor
Hairy Cell Leukemia (HCL)
Head and Neck Cancer
Heart Cancer
Hemochromatosis
Hemolytic Anemia
Hemophilia
Hepatocellular Cancer
Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Hereditary Spherocytosis
Hodgkin Lymphoma
Hurthle Cell Carcinoma
Hypopharyngeal Cancer
Hypopharyngeal Cancer
Idiopathic Thrombocytopenic Purpura (ITP)
Immunotherapy
In-situ Breast Cancer
Incontinence After Prostate Surgery
Inflammatory Breast Cancer
Inherited Bone Marrow Failure Syndromes (IBMFS)
Intensity Modulated Radiation Therapy
Intraocular Melanoma
Invasive Breast Cancer
Invasive Lobular Carcinoma
Iron-Deficiency Anemia
Islet Cell Tumor
Kaposi Sarcoma
Langerhans Cell Histiocytosis (LHC)
Large Cell Carcinoma
Large Granular Lymphocytic (LGL) leukemia
Leukemia
Leukopenia
Lip and Oral Cavity Cancer
Liver Cancer
Liver Cysts & Liver Tumors
Lung Cancer
Lymphatic Cancer
Lymphocytosis
Male Breast Cancer
Malignant Fibrous Histiocytoma (MFH)
Malignant Mesothelioma
Malignant Soft Tissue Tumors
Mastocytosis
Mediastinal Tumor
Medullary Carcinoma
Melanoma
Merkel Cell Carcinoma
Metastatic Cancer
Metastatic Spinal Tumors
Metastatic Squamous Neck Cancer with Occult Primary
Metastatic Tumors
Monoclonal Gammopathy
Mouth Cancer
Multiple Endocrine Neoplasia (MEN) Syndromes
Multiple Myeloma
Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS)
Myelofibrosis
Myeloproliferative Neoplasms (MPN)
Nasal Cavity and Paranasal Sinus Cancer
Nasopharyngeal Cancer
Neuroendocrine Tumor
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
NUT Midline Carcinoma
Oncogenic Osteomalacia
Ophthalmic Cancer
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Ovarian Germ Cell Tumors
Ovarian Primary Peritoneal Cancer
Ovarian Sex Cord Stromal Tumor
Pancreatic Cancer
Pancreatic Neuroendocrine Tumor
Paraganglioma
Paraneoplastic Syndromes
Parathyroid Cancer
Parotid Gland Tumor
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric Chordomas
Pediatric Ependymoma
Pediatric Germ Cell Tumor
Pediatric Rhabdomyosarcoma
Pediatric Spinal Cord Tumor
Pediatric Spinal Tumor
Pediatric Vascular Tumors
Penile Cancer
Pernicious Anemia
Pharyngeal Cancer
Pheochromocytoma
Pigmented Villonodular Synovitis (PVNS)
Pineal Region Tumor
Plasma Cell Neoplasms
Pleural Tumor
Pleuropulmonary Blastoma
Polycythemia Vera
Porphyria
Post-Transplant Lymphoproliferative Disorder (PTLD)
Prostate Cancer
PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
Pulmonary Nodules
Pure Red Cell Aplasia (PRCA)
Rectal Cancer
Recurrent Cancer
Relapsed ALL
Relapsed AML
Relapsed Multiple Myeloma
Renal Cell Cancer
Retinoblastoma (Cancer of the Eye)
Retroperitoneal Tumor
Rhabdomyosarcoma
Salivary Gland Cancer
Sarcoma
Sezary Syndrome
Shwachman-Diamond syndrome (SDS)
Sickle Cell Anemia
Skin Cancer
Skull Base Tumor
Small Cell Carcinoma
Small Cell Lung Cancer
Small Intestine Cancer
Soft Tissue Sarcoma
Spinal Tumor
Squamous Cell Carcinoma (SCC)
Stage 4 Cancer
Stomach Cancer
Sun Exposure & Skin Cancer
Synovial Sarcoma
Testicular Cancer
Thalassemia
Throat Cancer
Thrombocytopenia
Thrombocytosis
Thrombophilia
Thrombotic Thrombocytopenic Purpura (TTP)
Thymoma and Thymic Carcinoma
Thymus Gland Tumor
Thyroid Cancer
Tracheobronchial Tumor
Transitional Cell Cancer
Urethral Cancer
Uterine Sarcoma
Vaginal Cancer
Vascular Tumor
Venous Thromboembolism (VTE)
Von Willebrand Disease
Vulvar Cancer
Waldenstrom Macroglobulinemia
Wilms Tumor